Revenue: The sum of all revenue fields included for a company's operating activities.
United Therapeutics Corporation (UTHR) had Revenue of $798.60M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$798.60M |
$309.50M |
|
$87.60M |
|
$711.00M |
|
$434.10M |
|
$364.50M |
|
$43.90M |
|
$408.40M |
|
$408.40M |
|
$309.50M |
|
$309.50M |
|
$309.50M |
|
$309.50M |
|
$364.50M |
|
$385.60M |
|
45.10M |
|
48.30M |
|
$6.86 |
|
$6.41 |
|
| Balance Sheet Financials | |
$3.83B |
|
$1.36B |
|
$4.08B |
|
$7.91B |
|
$527.10M |
|
-- |
|
$207.30M |
|
$734.40M |
|
$7.17B |
|
$7.06B |
|
$7.17B |
|
45.22M |
|
| Cash Flow Statement Financials | |
$652.90M |
|
$-464.60M |
|
$-292.40M |
|
$1.70B |
|
$1.59B |
|
$-104.10M |
|
$69.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.03% |
|
45.64% |
|
45.64% |
|
-- |
|
51.14% |
|
38.76% |
|
$515.80M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.52 |
|
2.11 |
|
42.75 |
|
4.31% |
|
4.38% |
|
3.91% |
|
4.31% |
|
$158.66 |
|
$10.68 |
|
$13.52 |
|